According to the researchers, the therapy, H84T-BanLec, holds unique promise. They hope to start human testing soon.
The potential therapy was derived from a banana protein.
A study published on January 13th, 2020 touted the development of a potential therapy that may be used to fight all known strains of the flu.
One week later, the first laboratory-confirmed case of SARS-CoV-2 triggered the two-and-a-half-year-long COVID-19 pandemic in the United States.
Interestingly, the worldwide research team behind the influenza report had also looked into the treatment of coronaviruses before the virus that temporarily halted their work arrived.
“At the time we thought MERS would be the big target, which we were worried about because of its 35% mortality rate,” said David Markovitz, M.D., professor of internal medicine, Division of Infectious Diseases at the University of Michigan Medical School. (MERS, or Middle Eastern Respiratory Syndrome, caused a brief outbreak in 2015 and resulted in 858 confirmed deaths.)
A study published in Cell Reports Medicine describes the effectiveness of H84T-BanLec against every coronavirus known to infect humans, including MERS, the original SARS, and SARS-CoV2, including the omicron variant. Markovitz is joined by two senior authors: Peter Hinterdorfer, Ph.D., of the Institute of Biophysics at Johannes Kepler University, and Kwok-Yung Yuen, MBBS, M.D., of the University of Hong Kong. Jasper Fuk-Woo Chan, M.D., of the University of Hong Kong, is the paper’s first author.
Continue reading… “New Banana-Derived Therapy Is Effective Against All Known Coronaviruses and Flu Strains”